Ruthenium- or osmium-based complex catalysts

US9802972B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9802972-B2
Application numberUS-201414896412-A
CountryUS
Kind codeB2
Filing dateJun 6, 2014
Priority dateJun 9, 2013
Publication dateOct 31, 2017
Grant dateOct 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides novel ruthenium or osmium based complex structures with a unique combination of ligands comprising a Schiff-base type ligand, a N-heterocyclic carbene ligand and a CO ligand which can be prepared according to two different routes involving easily accessible starting materials and which represent excellent catalysts for hydrogenating unsaturated compounds, oligomers and polymers, in particular at unforeseeably low temperatures.

First claim

Opening claim text (preview).

The invention claimed is: 1. A complex having the general formula (I) wherein: M is ruthenium or osmium; Y represents H, F, Cl, Br, I, CF 3 , pyridine, —OC 6 H 5 , CF 3 COO—, CH 3 SO 3 —, or BF 4 ; R 1 , R 2 , R 3 , and R 4 are identical or different and represent H; NO 2 ; CF 3 ; halogen; or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 substituents; or OR 7 , OC(═O)R 7 , CO(═O)R 7 , SO 3 R 7 , SO 3 N(R 7 ) 2 or SO 3 Na wherein R 7 represents H, straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or (N(R 8 ) 3 ) + X − wherein X is halide, and R 8 are identical or different and represent H; straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl, substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 substituents; or tris (C 1 -C 6 -alkoxy)silyl-C 1 -C 6 -alkyl, tris (C 6 -C 14 -aryloxy)silyl-C 1 -C 6 -alkyl, or tris(C 3 -C 10 -cycloalkoxy)silyl-C 1 -C 6 -alkyl; R 5 represents H; or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents; and R 6 represents H, or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 substituents. 2. The complex of general formula (I) according to claim 1 , wherein: M is ruthenium; Y is H or Cl; R 1 , R 2 , R 3 , and R 4 are identical or different and represent H; NO 2 ; F, Cl, or Br; or straight chain or branched, substituted or unsubstituted C 1 -C 8 -alkyl; or substituted or unsubstituted C 5 -C 8 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents; or OR 7 , OC(═O)R 7 , CO(═O)R 7 , SO 3 R 7 , SO 3 N(R 7 ) 2 or SO 3 Na wherein R 7 represents H, straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; R 5 represents H; or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents; and R 6 represents H, or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents. 3. The complex of general formula (I) according to claim 1 , wherein: M is ruthenium, Y is H or Cl, R 1 , R 2 , R 3 , and R 4 are all H or R 1 , R 3 , and R 4 are all H while R 2 is simultaneously NO 2 ; R 5 represents H; straight chain or branched, substituted or unsubstituted C 1 -C 8 -alkyl; or substituted or unsubstituted C 5 -C 8 -cycloalkyl; or substituted or unsubstituted C 6 -C 10 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents; and R 6 represents H, or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; or substituted or unsubstituted C 3 -C 10 -cycloalkyl; or substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents. 4. The complex of the general formula (I) according to claim 1 , wherein the N-heterocyclic carbene ligand comprises a cyclic carbene type ligand based on imidazoline or imidazolidine moieties and having at least one nitrogen as hetero atom present in the ring. 5. The complex according to claim 4 , wherein, in the N-heterocyclic carbene ligand in the complex of the general formula (I), R 6 and R 9 are identical or different and represent hydrogen, C 6 -C 24 -aryl, or form a cycloalkyl or aryl structure together with the carbon atoms to which they are bound, and R 10 and R 11 are identical or different represent straight-chain or branched C 1 -C 10 -alkyl, C 3 -C 10 -cycloalkyl, substituted or unsubstituted C 6 -C 24 -aryl, 2,6-diisopropylphenyl, 2,6-dimethylphenyl, 2,4,6-trimethylphenyl, C 1 -C 10 -alkylsulfonate, or C 6 -C 10 -arylsulfonate. 6. The complex according to claim 1 , wherein the N-heterocyclic carbene ligand in the complex of the general formula (I) has the structures (IIIa) to (IIIu), where “Ph” means in each case phenyl, “Bu” means in each case butyl, “Mes” represents in each case 2,4,6-trimethylphenyl, “Dipp” means in all cases 2,6-diisopropylphenyl, and “Dimp” means in each case 2,6-dimethylphenyl 7. The complex according to claim 1 , wherein the complex of general formula (I) is selected from the group consisting of (Ia)-IMes, (Ia)-SIMes, (Ia)-IPr, (Ib)-IMes, (Ib)-SIMes, (Ib)-IPr, (Ic)-IMes, (Ic)-SIMes, (Ic)-IPr, wherein “IMes” means N,N′-bis(mesityl)imidazol-2-ylidene, “SIMes” means N,N′-bis(mesityl)imidazolidin-2-ylidene, “IPR” means N,N′-bis(2,6-diisopropyl-phenyl)imidazol-2-ylidene and “ItBu” means N,N′-bis(tert-butyl)imidazol-2-ylidene, 8. A process for preparing the complex of general formula (I) according to claim 1 , the process comprising: reacting a compound of general formula (1) MXY(CO)(PR 3 ) n   (1) wherein: M is ruthenium or osmium; X is H, Cl, Br or I; Y represents H, F, Cl, Br, I, CF 3 , pyridine, —OC 6 H 5 , CF 3 COO—, CH 3 SO 3 —, or BF 4 ; R represents substituted or unsubstituted C 1 -C 14 -alkyl; substituted or unsubstituted C 3 -C 8 -cycloalkyl; substituted or unsubstituted C 6 -C 14 -aryl; and n is 3, if R represent substituted or unsubstituted C 6 -C 14 -aryl; or n is 2, if R represent substituted or unsubstituted C 1 -C 14 -alkyl, or substituted or unsubstituted C 3 -C 8 -cycloalkyl; with a compound of general formula (2) wherein R 1 , R 2 , R 3 , and R 4 are identical or different and represent H; NO 2 ; CF 3 ; halogen; or straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; substituted or unsubstituted C 3 -C 10 -cycloalkyl; substituted or unsubstituted C 6 -C 14 -aryl, which aryl group is either unsubstituted or contains 1, 2, 3, 4 or 5 identical or different substituents; OR 7 , OC(═O)R 7 , CO(═O)R 7 , SO 3 R 7 , SO 3 N(R 7 ) 2 or SO 3 Na wherein R 7 represents H, straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl; (N(R 8 ) 3 ) + X − wherein X is halide, and R 8 are identical or different and represent H; straight chain or branched, substituted or unsubstituted C 1 -C 14 -alkyl, substituted or unsubstituted C 6 -C 14 -aryl, which aryl

Assignees

Inventors

Classifications

  • At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand · CPC title

  • of C=C or C-C triple bonds · CPC title

  • Hydrogenation · CPC title

  • of non-aromatic carbon-to-carbon double bonds · CPC title

  • Ruthenium compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9802972B2 cover?
The present invention provides novel ruthenium or osmium based complex structures with a unique combination of ligands comprising a Schiff-base type ligand, a N-heterocyclic carbene ligand and a CO ligand which can be prepared according to two different routes involving easily accessible starting materials and which represent excellent catalysts for hydrogenating unsaturated compounds, oligomer…
Who is the assignee on this patent?
Lanxess Deutschland Gmbh, Arlanxeo Deutschland Gmbh
What technology area does this patent fall under?
Primary CPC classification C07F15/0046. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).